rs11171661

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002206.3(ITGA7):​c.415-10C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0849 in 1,613,994 control chromosomes in the GnomAD database, including 6,764 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.063 ( 444 hom., cov: 33)
Exomes 𝑓: 0.087 ( 6320 hom. )

Consequence

ITGA7
NM_002206.3 intron

Scores

2
Splicing: ADA: 0.00001970
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -1.35

Publications

6 publications found
Variant links:
Genes affected
ITGA7 (HGNC:6143): (integrin subunit alpha 7) The protein encoded by this gene belongs to the integrin alpha chain family. Integrins are heterodimeric integral membrane proteins composed of an alpha chain and a beta chain. They mediate a wide spectrum of cell-cell and cell-matrix interactions, and thus play a role in cell migration, morphologic development, differentiation, and metastasis. This protein functions as a receptor for the basement membrane protein laminin-1. It is mainly expressed in skeletal and cardiac muscles and may be involved in differentiation and migration processes during myogenesis. Defects in this gene are associated with congenital myopathy. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Feb 2009]
ITGA7 Gene-Disease associations (from GenCC):
  • congenital muscular dystrophy due to integrin alpha-7 deficiency
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • congenital fiber-type disproportion myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 12-55701164-G-A is Benign according to our data. Variant chr12-55701164-G-A is described in ClinVar as Benign. ClinVar VariationId is 94045.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0995 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ITGA7NM_002206.3 linkc.415-10C>T intron_variant Intron 3 of 24 ENST00000257879.11 NP_002197.2 Q13683-7Q4LE35

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ITGA7ENST00000257879.11 linkc.415-10C>T intron_variant Intron 3 of 24 1 NM_002206.3 ENSP00000257879.7 Q13683-7

Frequencies

GnomAD3 genomes
AF:
0.0630
AC:
9593
AN:
152176
Hom.:
444
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0166
Gnomad AMI
AF:
0.0636
Gnomad AMR
AF:
0.0550
Gnomad ASJ
AF:
0.0496
Gnomad EAS
AF:
0.000577
Gnomad SAS
AF:
0.0134
Gnomad FIN
AF:
0.0655
Gnomad MID
AF:
0.0759
Gnomad NFE
AF:
0.102
Gnomad OTH
AF:
0.0684
GnomAD2 exomes
AF:
0.0627
AC:
15748
AN:
251000
AF XY:
0.0626
show subpopulations
Gnomad AFR exome
AF:
0.0168
Gnomad AMR exome
AF:
0.0386
Gnomad ASJ exome
AF:
0.0491
Gnomad EAS exome
AF:
0.000272
Gnomad FIN exome
AF:
0.0643
Gnomad NFE exome
AF:
0.0994
Gnomad OTH exome
AF:
0.0721
GnomAD4 exome
AF:
0.0872
AC:
127496
AN:
1461700
Hom.:
6320
Cov.:
33
AF XY:
0.0854
AC XY:
62102
AN XY:
727172
show subpopulations
African (AFR)
AF:
0.0132
AC:
442
AN:
33480
American (AMR)
AF:
0.0408
AC:
1824
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0493
AC:
1288
AN:
26136
East Asian (EAS)
AF:
0.000252
AC:
10
AN:
39700
South Asian (SAS)
AF:
0.0185
AC:
1596
AN:
86256
European-Finnish (FIN)
AF:
0.0700
AC:
3735
AN:
53354
Middle Eastern (MID)
AF:
0.0434
AC:
250
AN:
5766
European-Non Finnish (NFE)
AF:
0.102
AC:
113669
AN:
1111898
Other (OTH)
AF:
0.0775
AC:
4682
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
6734
13467
20201
26934
33668
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4044
8088
12132
16176
20220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0629
AC:
9585
AN:
152294
Hom.:
444
Cov.:
33
AF XY:
0.0609
AC XY:
4534
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.0166
AC:
688
AN:
41570
American (AMR)
AF:
0.0548
AC:
839
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0496
AC:
172
AN:
3466
East Asian (EAS)
AF:
0.000578
AC:
3
AN:
5188
South Asian (SAS)
AF:
0.0135
AC:
65
AN:
4830
European-Finnish (FIN)
AF:
0.0655
AC:
695
AN:
10618
Middle Eastern (MID)
AF:
0.0680
AC:
20
AN:
294
European-Non Finnish (NFE)
AF:
0.101
AC:
6902
AN:
68004
Other (OTH)
AF:
0.0676
AC:
143
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
461
921
1382
1842
2303
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
114
228
342
456
570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0756
Hom.:
144
Bravo
AF:
0.0603
Asia WGS
AF:
0.0110
AC:
37
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Mar 31, 2021
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 26, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Sep 20, 2012
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital muscular dystrophy due to integrin alpha-7 deficiency Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
2.3
DANN
Benign
0.84
PhyloP100
-1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000020
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11171661; hg19: chr12-56094948; API